Print this page

NZ start-up set to disrupt $40b industry

  • font size decrease font size decrease font size increase font size increase font size
  A handheld device which can generate quicker and more accurate results for substances such as recreational drugs is being developed in Wellington. Photo: Supplied A handheld device which can generate quicker and more accurate results for substances such as recreational drugs is being developed in Wellington. Photo: Supplied

A Wellington-based start-up is poised to disrupt a $40 billion antibodies industry by creating a faster, cheaper and humane way of testing for substances reports Farah Hancock for Newsroom.

It all comes down to aptamers, short strands of DNA which can mimic the action of antibodies traditionally used for testing.

AuramerBio, a biotech company spun out of the MacDiarmid Institute, is about to field trial their first biosensing product. Their handheld device can be used roadside, in workplaces or in hospital triages to tests for recreational drugs.

In just three minutes a saliva sample can identify if you have taken any of six different recreational drugs. Unlike traditional roadside testing units, AuramerBio’s device can detect the levels of drugs in saliva, not just the presence. . . . read on >